Skip to content

Medical-device intelligence

CFL: Radioimmunoassay, Human Growth Hormone

FDA product code CFL: Radioimmunoassay, Human Growth Hormone. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
CFL
FDA device name
Radioimmunoassay, Human Growth Hormone
Device class
1
Regulation number
862.1370
Medical specialty
Clinical Chemistry
Review panel
CH

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

36 clearance records and 5 recall records in the covered releases, across 23 source company names and 1 product codes. Dated history runs from Apr 12, 1978 to Mar 5, 2018.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
CFL · Radioimmunoassay, Human Growth Hormone365

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

41 matching records
Device / recordCompany in FDA recordSourceSource date
ST-AIA PACK HGH; Part Number: 025266 Assay, MetabolicZ-2095-2018 · CFLTosoh Bioscience IncRecallJun 5, 2018FDA record creation date
IG1, IGF-I reagent, Catalog # LKGF1; For the quantitative measurement of insulin-like growth factor I (IGF-I) in serum or heparinized plasma.Z-2841-2016 · CFLSiemens Healthcare Diagnostics, Inc.RecallSep 16, 2016FDA classification date
IGFBP-3 ELISA Reagent Kit; Part Number" DSL-10-6600; Lot Numbers: 992743, 992287, 991916, 991530, 991432, 990220 & 890830 This assay is intended…Z-2184-2011 · CFLBeckman Coulter Inc.RecallMay 11, 2011FDA classification date
IGFBP-3 Immunoradiometric Assay (IRMA) Kit, Part Number: DSL-6600 usage: The DSL6600 IGFBP-3 immunoradiometric assay (IRMA) kit provides materi…Z-2607-2010 · CFLBeckman Coulter Inc.RecallSep 28, 2010FDA classification date
Nichols Advantage Sample hGH Diluent Set (Catalog No. 62-7756)Z-0873-05 · CFLNichols Institute DiagnosticsRecallJun 4, 2005FDA classification date
SEALITE SCIENCES, INC. AQUALITE HUMAN GROWTH HORMONE ASSAYK972761 · CFLSealite Sciences, Inc.510(k)Sep 25, 1997FDA decision date
DSL ACTIVE NON-EXTRACTION IGF-I ELISAK971353 · CFLDiagnostic Systems Laboratories, Inc.510(k)May 12, 1997FDA decision date
DSL 1900 ACTIVE HUMAN GROWTH HORMONE IRMA (DSL 1900)K970701 · CFLDiagnostic Systems Laboratories, Inc.510(k)Apr 2, 1997FDA decision date
DSL 9100 IGF-II IRMAK962758 · CFLDiagnostic Systems Laboratories, Inc.510(k)Aug 30, 1996FDA decision date
HUMAN GROWTH HORMONE IMMUNOASSAY KITK961678 · CFLNichols Institute Diagnostics510(k)Jul 8, 1996FDA decision date
DSL ACTIVE NON-EXTRACTION IGF-I IRMAK961172 · CFLDiagnostic Systems Laboratories, Inc.510(k)Apr 23, 1996FDA decision date
DSL ACTIVE HUMAN GROWTH HORMONE ELISAK960551 · CFLDiagnostic Systems Laboratories, Inc.510(k)Mar 6, 1996FDA decision date
IMMULITE HGHK955376 · CFLDiagnostic Products Corp.510(k)Feb 16, 1996FDA decision date
INSULIN-LIKE GROWTH FACTOR-I (IGF-I) IMMUNORADIOMETRIC ASSAYK955390 · CFLCorning Nichols Diagnostics510(k)Dec 29, 1995FDA decision date
INSULIN-LIKE GROWTH FACTOR I (IGF-I), IMMUNORADIOMETERIC ASSAY (IRMA)K952505 · CFLNichols Institute510(k)Jul 3, 1995FDA decision date
IGFBP-3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3K946247 · CFLNichols Institute510(k)Jun 23, 1995FDA decision date
DSL ACTIVE IFGBP-3 ELISAK951707 · CFLDiagnostic Systems Laboratories, Inc.510(k)May 10, 1995FDA decision date
ACTIVE IGF-I ELISAK951752 · CFLDiagnostic Systems Laboratories, Inc.510(k)May 10, 1995FDA decision date
OCTEIA IGF-1 KITK950510 · CFLImmunodiagnostic Systems , Ltd.510(k)Apr 5, 1995FDA decision date
DSL ACTIVE IGFBP-3 IRMA (DSL 6600)K950228 · CFLDiagnostic Systems Laboratories, Inc.510(k)Feb 22, 1995FDA decision date
DSL IGFBP-3 RIA (DSL 6700)K930047 · CFLDiagnostic Systems Laboratories, Inc.510(k)Jul 6, 1994FDA decision date
ENDOCRINE SCIENCES PRODUCTS IGFBP3 RADIOIMMUNO KITK921868 · CFLEndocrine Sciences Products510(k)Jan 3, 1994FDA decision date
DELFIA(R) HGH KITK930484 · CFLWallac OY510(k)May 11, 1993FDA decision date
MEDIX BIOTECH HGHENZYME IMMUNOASSAY TEST KITK920299 · CFLMedix Biotech, Inc.510(k)Mar 4, 1992FDA decision date
LONDON DIAGNOSTICS LUMATAG(R) HGH CHEM IMMUN ASSAYK912858 · CFLLondon Diagnostics, Inc.510(k)Jul 30, 1991FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗